Morningstar backs QBE Insurance

The global insurer's results didn't impress investors but the company still has some supporters.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investment house Morningstar has come out backing QBE Insurance (ASX: QBE). Mr Peter Warnes, Head of Equities Research at Morningstar, noted in a recent interview that despite disappointments there were some positives in QBE's interim result.

Specifically, Mr Warnes highlighted the benefits from adjustments to the discount rate thanks to favourable moves in bond yields. For the six months to June the discount rate benefit only just covered the increased US$178 million of claims from prior year losses which "popped up." However looking forward, with bond yields continuing to improve Warnes, is focussing on the positive yield environment QBE is entering.

Warnes also made the point that QBE experiences many of its costs in the first half with earnings skewed to a seasonally stronger second half. With the USA crop harvest looking healthy, earnings from the North American crop insurance business have the potential to be much better this year than last.

Foolish takeaway

QBE reported a fall in net profit of 37%, making it clearly the least impressive result from the major insurers. Suncorp (ASX: SUN) managed to increase its underlying profits by 19%, while Insurance Australia Group (ASX: IAG) reported a significant boost to both earnings and dividends for shareholders.

With QBE's earnings coming off a low base and with a share price which has underperformed its peers by around 20% over the past year there could still be further upside for QBE, however the complexity of its accounts make an investment in QBE a higher risk option.

Looking for a lower risk option? Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tim McArthur owns shares in QBE Insurance.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »